Simply Oncology Podcast Por John McGrane & Michael Rowe arte de portada

Simply Oncology
The buy box is not available to display at this moment. We apologize for the inconvenience
To purchase this book, please visit this page again later. For help with any other issue, please call our 24/7 customer service

Welcome to Simply Oncology.
Cancer is daunting for both patients and for clinical teams.
Dr John McGrane and Dr Michael Rowe are oncologists who want to break down the complex parts of cancer care into clear and simple sessions.
We will dive deep into the world of cancer research, patient stories and the latest cancer breakthroughs.
Simply Oncology will have patient focused episodes along with episodes that allow anyone with an interest in oncology to stay up to date.

We hope you join us as we unpick all parts of cancer.

John & Mike

© 2026 Simply Oncology Ciencia Ciencias Biológicas Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Episode 91: In the Clinic - Biomarkers in advanced Kidney Cancer with Professor Laurence Albiges (part 2)

    Episode 91: In the Clinic - Biomarkers in advanced Kidney Cancer with Professor Laurence Albiges (part 2)
    Feb 26 2026

    Send a text

    Join us as return to our excellent conversation on biomarkers in kidney cancer with the wonderful Professor Laurence Albiges from Paris.
    Más Menos
    19 m
  • Episode 90: Biomarkers in Advanced Kidney Cancer with Professor Laurence Albiges (Part 1/2)

    Episode 90: Biomarkers in Advanced Kidney Cancer with Professor Laurence Albiges (Part 1/2)
    Feb 19 2026

    Send a text

    Join us for a special Kidney Cancer treat!!!

    We discuss the role of biomarkers in advanced kidney cancer with the wonderful Professor Laurence Albiges from the Gustave Roussy Institute of Oncology in Paris.

    No Kidney Cancer talk is complete without the question -" Where are we with biomarkers?"

    This is part 1 of a 2 part walkthrough of the biomarker story so far in kidney cancer.

    Laurence is unequalled in her clear delivery on this subject.

    As lead for the CARE-1 study Laurence is examining the role of PDL1 as a biomarker in 1st line treatment of mRCC.

    We also discuss the;

    - IMDC criteria

    - Clusters

    - KIM-1

    - PDL1

    - Sarcomatoid features

    Recorded before Christmas this is a gift that keeps on giving.

    We hope you enjoy!!

    Check the Transcript for more details.
    Más Menos
    25 m
  • Episode 89: In the Clinic - Advanced Renal Cancer The Sequel: Professor Ricky Frazer Returns (part 2/2)

    Episode 89: In the Clinic - Advanced Renal Cancer The Sequel: Professor Ricky Frazer Returns (part 2/2)
    Feb 5 2026

    Send a text

    Join us as we return to complete our run through the landscape of metastatic renal cancer with the effervescent Professor Ricky Frazer.

    We look at the Dolly Mixture of subtypes that makes up non clear cell renal carcinoma.

    We discuss the new HIF2a inhibitors such as belzutifan.

    We look at future directions in kidney cancer.

    A treat for anyone who treats kidney cancer.

    Enjoy!
    Más Menos
    19 m
Todavía no hay opiniones